Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.77 CHF | +1.03% | +2.84% | -0.41% |
Sales 2023 * | 8.29M 9.18M | Sales 2024 * | 51.09M 56.6M | Capitalization | 90M 99.7M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 10.9 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.76 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 46 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 70.73% |
Latest transcript on Santhera Pharmaceuticals Holding AG
1 day | +1.03% | ||
1 week | +2.84% | ||
Current month | -6.06% | ||
1 month | -10.86% | ||
3 months | -1.71% | ||
6 months | +21.07% | ||
Current year | -0.41% |
Managers | Title | Age | Since |
---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 56 | 19-11-30 |
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Andrew P. Smith
DFI | Director of Finance/CFO | 61 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Director/Board Member | 56 | 17-04-03 | |
Otto Schwarz
BRD | Director/Board Member | 68 | 23-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 9.77 | +1.03% | 21,856 |
24-03-27 | 9.67 | -1.12% | 20,901 |
24-03-26 | 9.78 | +0.82% | 50,502 |
24-03-25 | 9.7 | +1.04% | 30,774 |
24-03-22 | 9.6 | +1.05% | 11,600 |
Delayed Quote Swiss Exchange, March 28, 2024 at 12:30 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.41% | 99.93M | |
+13.52% | 9.63B | |
-7.87% | 5.37B | |
+12.50% | 4.28B | |
+18.09% | 3.71B | |
+42.95% | 2.91B | |
-19.01% | 2.54B | |
-20.66% | 2.37B | |
+17.86% | 1.87B | |
-0.50% | 1.64B |